The Latin America, Middle East and Africa Clinical Decision Support Systems Market would witness market growth of 15.2% CAGR during the forecast period (2021-2027).
The introduction of CDSS as a supportive tool can help healthcare entities overcome the challenges of making high-quality clinical decisions. CDSS has been recognized as a critical instrument for overcoming challenges in providing high-quality treatment to patients by enhancing and streamlining healthcare delivery.
The enforcement of government restrictions and efforts to encourage the deployment of HIT solutions, rising adoption of CDSS-enabled EHRs, the growing number of collaborations and partnerships between stakeholders, rising incidence of medication errors, and the rising prominence of mHealth and big data tools are the key factors propelling the growth of this market. However, the high costs of implementing CDSS, as well as a lack of interoperability and data security concerns, are projected to limit the market's growth throughout the forecasting period.
LAMEA is a lucrative hub for the clinical decision support systems market. The healthcare infrastructure of countries that lies in LAMEA is weaker when compared to other regions. In addition, a substantial number of deaths that are being caused by multiple diseases make the region highly conducive for the demand and growth of equipment that comprises the ability to strengthen the healthcare services in countries across the region.
The Brazil market dominated the LAMEA Clinical Decision Support Systems Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $151.1 million by 2027. The Argentina market would exhibit a CAGR of 15.8% during (2021 - 2027). Additionally, The UAE market is poised to grow a CAGR of 14.9% during (2021 - 2027).
Based on Component, the market is segmented into Services, Hardware, and Software. Based on Product, the market is segmented into Standalone CDSS, Integrated CDSS with CPOE & E.H.R., Integrated E.H.R. with CDSS, and Others. Based on Delivery Mode, the market is segmented into On-premise Systems, Web-based Systems, and Cloud-based Systems. Based on Application, the market is segmented into Drug Allergy Alerts, Drug-drug Interactions, Clinical Guidelines, Drug Dosing Support, Clinical Reminders, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Clinical Decision Support Systems Market is Predict to reach $8.2 Billion by 2027, at a CAGR of 10.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Siemens Healthineers AG (Siemens AG), Cerner Corporation (Oracle Corporation), AllScripts Healthcare Solutions, Inc., General Electric (GE) Co. (GE Healthcare), NextGen Healthcare, Inc., Athenahealth, Inc. (Veritas Capital), Epic Systems Corporation, eClinicalWorks LLC, Change Healthcare, Inc., and Zynx Health, Inc. (Hearst Communications, Inc.).
By Component
By Product
By Delivery Mode
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 